Home › Funds › Two Sigma Investments › VRTX
Two Sigma Investments position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)287.40K sh
Reported value held$142.76M
Portfolio Weight0.11%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 959.68K | $174.08M | New |
| Q1 2022 | 33.64K | $8.78M | New |
| Q4 2022 | 29.12K | $8.41M | New |
| Q1 2023 | 91.25K | $28.75M | Add |
| Q2 2023 | 388.88K | $136.85M | Add |
| Q3 2023 | 259.43K | $90.21M | Reduce |
| Q4 2023 | 136.17K | $55.41M | Reduce |
| Q1 2024 | 324.43K | $135.61M | Add |
| Q2 2024 | 331.99K | $155.61M | Add |
| Q3 2024 | 160.53K | $74.66M | Reduce |
| Q4 2024 | 33.16K | $13.35M | Reduce |
| Q1 2025 | 4.12K | $2.00M | Reduce |
| Q4 2025 | 4.16K | $1.88M | New |
| Q1 2026 | 379.15K | $169.30M | Add |
| Q2 2026 | 287.40K | $142.76M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026